Skip to main content

ALPS ADVISORS INC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1376113 Denver, CO

Position in BCRX

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$573,580
-$193,958 QoQ
Shares Held
60,250
-40.4% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

ALPS ADVISORS INC holds $13,007,217 across 10 Drug Manufacturers - Specialty & Generic names. BCRX ranks #5 (4.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 BCRX
Biocryst Pharmaceuticals Inc
This page
60,250 $573,580

All Filings in BCRX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $573,580 60,250
2025-09-30 $767,538 101,125
2025-06-30 $1,011,001 112,835
2025-03-31 $1,147,387 152,985
2024-12-31 $1,259,539 167,492
2024-09-30 $1,201,636 158,110
2024-06-30 $994,998 161,003
2024-03-31 $738,662 145,406
2023-12-31 $827,224 138,101
2023-09-30 $990,138 139,850
2023-06-30 $977,701 138,878
2023-03-31 $1,024,302 122,818
2022-12-31 $1,450,762 126,373
2022-09-30 $1,279,391 101,539
2022-06-30 $1,165,016 110,115